Strategic funding Index Ventures demonstrates a strong track record of leading and co-leading large funding rounds across AI, security, and life sciences (e.g., Glow Security Series A, Fireworks AI Series D, Chai Discovery Series C, BRINC Drones financing). This suggests opportunities to position security, AI, and biotech innovators as potential co-investors or portfolio synergies with Index’s deep founder network.

Global collaboration With offices across London, Tel Aviv, San Francisco, and New York, Index Ventures emphasizes cross-border support and scale-up guidance. Sales outreach can highlight international market entry planning, cross-region partnerships, and global go-to-market services aligned with Index’s atlas of networks.

Portfolio synergies Index-backed companies span AI, drone tech, drug discovery, cybersecurity, and enterprise software. A proactive approach would map potential customer and partner logos within the portfolio to identify co-sell, technology integration, or pilot opportunities that leverage Index’s relationships with both founders and strategic investors.

Early-stage focus Index frequently engages at Seed and Series A stages, expanding to IPO and beyond. This positions opportunities for early engagement in deals with high growth potential, enabling you to offer scalable GTM support, pilot programs, or go-to-market partnerships as these portfolio companies mature.

Impact and ecosystem Index emphasizes positive impact and support for nonprofits, education, healthcare, and research endowments. This signals potential buyers or collaborators in impact-focused sectors, as well as opportunities to offer ESG-aligned technology solutions, sustainability analytics, or grant-backed pilots to Index’s investor base.